Expression of Concern: Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma
Yongshun Zheng, Ran Jia, Jun Li, Xiaohe Tian, Yeben Qian
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCurcumin's Biomedical Applications · RNA Interference and Gene Delivery · Computational Drug Discovery Methods
Expression of Concern: Journal of Nanobiotechnology (2022) 20: 339
10.1186/s12951-022-01554-y
The Editor-in-Chief would like to alert the readers that concerns have been raised regarding the data presented in Fig. 6a.
After publication, a reader noted high similarity between Fig. 6a Spleen images representing the CUR + RSV and NP groups. The authors stated that the images from the same sample were included in the figure by mistake, and provided the full original data for validation. However, further checks by the Publisher and Associate Editors identified potential issues in sample preparation in the majority of the original images, deeming that the data were insufficient to fully support the authors’ statement that the tissues displayed no abnormalities or organ damage.
Readers are therefore advised to interpret these results with caution.
Yeben Qian has stated on behalf of all authors that they agree to this Editorial Expression of Concern.